Factor fueling the growth of the Pharmaceutical Industry

1
Indian Pharma PCD Franchise Factors Fueling its
Growth
2

• The global pharma market is going through a
  significant transformation, especially for us in
  the Indian sector. As the developed markets face
  a slowdown, it is the emerging markets that are
  emerging as a viable alternative. This is good
  news for Indian companies that are uniquely
  poised to take the lead position in the decade to
  come.
• Closely linked with the success story of the
  bigger companies is the role of other smaller
  players, such as Indian pharma franchise company.
  In this growth story it is part of other emerging
  markets like Brazil, Russia and China. But there
  are reasons why many investors are upbeat over
  India's chances against its competitors. This is
  because Indian firms offer certain unique
  advantages.
• The factors behind the Indian pharma sector's
  growth lies in the organic nature of its
  development.

3
Presence Of Branded Drugs

• Although Indian is seen as the leader in generic
  drugs worldwide, the Indian market is today
  dominated by branded drugs. According to the
  latest McKinsey report, 70-80 percent of the
  market is dominated by this sector. This is great
  news because even through generic drugs drive our
  volumes, it is the branded drugs that get the big
  revenue.
• This also gives us an edge internationally. It
  exhibits Indian companies', including the pharma
  pcd franchises', ability to lead in both sectors.
  It shows that unlike its competitors Indian
  firms' expertise does not lie solely in creating
  cheaper knock-off of more expensive drugs.

4
Strong Local Companies

• When we closely look at the rise of the pharma
  sector in many other countries, we find one
  rather unwelcome data. The rise of pharma in
  emerging market is actually fueled by the top
  international firms who were creating their
  second base away front the slowly declining
  developed market. So, even though we were seeing
  an emergence of these markets, much of the
  benefit was going to the already established
  players.
• This is where India differs significantly. Unlike
  many other developing nation, India has a core
  set of strong business houses, entrepreneurs and
  a history in pharma research and industry. There
  are industry leaders who have coped with daunting
  odds of government red tape and low investment,
  while trying to develop and sell medicines to a
  fairly low value market. What this has given us
  is a strong backbone of local investments,
  workforce and market rules. It has also reduced
  our dependence on international firms, keeping
  the growth and revenues within the local
  industry.

5
Cost Benefit

• Like a lot of emerging markets the Indian pharma
  sector has also benefitted from the surging costs
  of drugs and medical care in developed countries.
  The truth is that many drugs are overcharged by
  massive margins in these countries. Even
  accounting for their RD investment, the drugs,
  many of which are lifesaving, are too steeply
  priced.
• Indian drugs, on the other hand, are
  significantly cheaper. Local and inter nation
  competition has further kept the costs fairly
  low. In many pooper countries like many of the
  African countries, Indian companies are the
  leaders. The result is that Indian drug sales
  lead in volume with a dominance over
  international markets.

6
Strong Medical Infrastructure

• Unlike many of the emerging markets, the Indian
  pcd pharma franchise company success is also
  backed by a strong medical infrastructure. This
  includes leading hospital, patient care
  facilities, accomplished doctors, RD facilities
  and established medical colleges that ensure a
  professional backbone to the medical industry.
• In other words, the Indian pharma story has not
  grown in isolation. It has grown as a response to
  rising health consciousness, local demand for
  better medicines and competition. This
  infrastructure gives the industry a much needed
  foundation and an organic growth pattern one that
  is essential to ensure sustainable growth and
  development.
• Rising demand The strongest factor in the growth
  of the Indian pharma sector is its organic
  nature. It has grown because of local demands and
  requirement. As the prevalence of chronic
  diseases becomes more common, the demand for
  treatment and cure has also gone up. This has
  fueled investment and RD - the two essential
  factors in the growth of any pharma industry.

7
Conclusion

• While the global slowdown may have given it a
  fillip, the Indian pharma franchise company story
  no flash in the pan. Its current leading position
  is the result of a strong local demand,
  infrastructure and emerging competitors.

8
Phone [phone]Cell 91 9033028080,
8469228080Fax [phone]
106,Scarlet Gateway,Corporate Road,Opp.Rivera
Antilia,Prahlad Nagar,Ahmedabad-380015Gujarat,
India
www.fitwelpharma.com